Published in Vaccine on August 30, 2006
Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol (2007) 2.30
Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults. J Infect Dis (2011) 2.25
Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. J Virol (2007) 1.32
West Nile virus. Clin Lab Med (2010) 1.10
TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol (2010) 1.09
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine (2006) 1.00
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol (2009) 0.97
Current trends in West Nile virus vaccine development. Expert Rev Vaccines (2014) 0.93
Vaccines in development against West Nile virus. Viruses (2013) 0.90
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Clin Vaccine Immunol (2007) 0.88
Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model. Virol J (2012) 0.86
Tick-borne Encephalitis Vaccines. J Bioterror Biodef (2011) 0.85
Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line. Virol J (2007) 0.84
West nile virus: characteristics of an african virus adapting to the third millennium world. Open Virol J (2010) 0.83
A review of vaccine approaches for West Nile virus. Int J Environ Res Public Health (2013) 0.83
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Vaccine (2008) 0.82
Flavitrack analysis of the structure and function of West Nile non-structural proteins. Int J Bioinform Res Appl (2010) 0.80
Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1. Vector Borne Zoonotic Dis (2012) 0.78
Recent advances in the production of recombinant subunit vaccines in Pichia pastoris. Bioengineered (2016) 0.77
Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters. Am J Trop Med Hyg (2008) 0.77
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PLoS One (2016) 0.76
Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery. Toxins (Basel) (2014) 0.75
Optimized expression of the antimicrobial protein Gloverin from Galleria mellonella using stably transformed Drosophila melanogaster S2 cells. Cytotechnology (2017) 0.75
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Cell lines derived from late embryonic stages of Drosophila melanogaster. J Embryol Exp Morphol (1972) 9.58
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A (2003) 7.76
West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet (2001) 6.49
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol (2005) 3.58
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis (2001) 2.85
Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis (2001) 2.72
West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica (2006) 2.67
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol (2002) 2.66
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis (2001) 2.34
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol (2001) 2.09
West Nile virus encephalitis. N Engl J Med (2002) 1.94
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol (2006) 1.91
The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology (1993) 1.74
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci U S A (2002) 1.65
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis (2002) 1.64
Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol (2001) 1.60
Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells. Genes Dev (1989) 1.56
Regulated expression allows high level production and secretion of HIV-1 gp120 envelope glycoprotein in Drosophila Schneider cells. Biotechnology (N Y) (1991) 1.44
Equine vaccine for West Nile virus. Dev Biol (Basel) (2003) 1.37
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest (1996) 1.35
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch Virol Suppl (2004) 1.34
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol (1995) 1.32
A recombinant envelope protein vaccine against West Nile virus. Vaccine (2005) 1.31
A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol (2003) 1.31
A live attenuated West Nile virus strain as a potential veterinary vaccine. Viral Immunol (2000) 1.24
West Nile virus vaccine. Curr Drug Targets Infect Disord (2001) 1.18
Update on cytokines. J Allergy Clin Immunol (1996) 1.06
Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci (2001) 1.00
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine (2006) 1.00
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix. Vaccine (1995) 0.92
Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine (2000) 0.90
Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine (2003) 0.88
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A (2003) 7.76
Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis (2011) 6.06
Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis (2012) 5.31
Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol (2005) 3.58
Persistent infection with West Nile virus years after initial infection. J Infect Dis (2010) 3.33
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Zika virus infection, Cambodia, 2010. Emerg Infect Dis (2012) 3.07
A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLoS Pathog (2012) 2.63
Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg (2005) 2.60
Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology (2003) 2.59
Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet (2002) 2.56
West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis (2003) 2.27
Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis (2010) 2.17
Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis (2005) 2.03
The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg (2004) 2.02
Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res (2013) 1.93
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am J Trop Med Hyg (2007) 1.86
An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg (2008) 1.83
Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr (2005) 1.82
Emergence of attenuated West Nile virus variants in Texas, 2003. Virology (2004) 1.75
Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis (2004) 1.73
Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS (2003) 1.72
Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002. Emerg Infect Dis (2003) 1.71
Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution. J Virol (2012) 1.67
Introductions of West Nile virus strains to Mexico. Emerg Infect Dis (2006) 1.61
Genetic divergence and dispersal of yellow fever virus, Brazil. Emerg Infect Dis (2004) 1.60
Molecular epidemiology of group C viruses (Bunyaviridae, Orthobunyavirus) isolated in the Americas. J Virol (2005) 1.60
The importance of leptospirosis in Southeast Asia. Am J Trop Med Hyg (2002) 1.57
Yunnan orbivirus, a new orbivirus species isolated from Culex tritaeniorhynchus mosquitoes in China. J Gen Virol (2005) 1.54
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol (2005) 1.53
Identification of novel viruses using VirusHunter--an automated data analysis pipeline. PLoS One (2013) 1.53
Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. J Infect Dis (2013) 1.51
Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad. Virology (2009) 1.51
Dengue emergence and adaptation to peridomestic mosquitoes. Emerg Infect Dis (2004) 1.50
Massilia virus, a novel Phlebovirus (Bunyaviridae) isolated from sandflies in the Mediterranean. Vector Borne Zoonotic Dis (2009) 1.50
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol (2006) 1.49
Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg Infect Dis (2008) 1.49
Host feeding pattern of Culex quinquefasciatus (Diptera: Culicidae) and its role in transmission of West Nile virus in Harris County, Texas. Am J Trop Med Hyg (2007) 1.48
Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis (2004) 1.47
Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg Infect Dis (2004) 1.43
Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses. J Virol (2013) 1.43
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis (2005) 1.43
Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg (2011) 1.42
Dengue vaccines: progress and challenges. Curr Opin Immunol (2011) 1.40
Quaranfil, Johnston Atoll, and Lake Chad viruses are novel members of the family Orthomyxoviridae. J Virol (2009) 1.40
The genome of Yoka poxvirus. J Virol (2011) 1.39
Endemic eastern equine encephalitis in the Amazon region of Peru. Am J Trop Med Hyg (2007) 1.38
Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am J Trop Med Hyg (2005) 1.36
Sexual networks of pregnant women with and without HIV infection. AIDS (2003) 1.34
Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. Am J Trop Med Hyg (2003) 1.33
Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species. J Virol (2013) 1.33
Nyamanini and midway viruses define a novel taxon of RNA viruses in the order Mononegavirales. J Virol (2009) 1.33
Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons. Neuron (2010) 1.33
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine (2010) 1.33
Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg (2006) 1.33
Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003). PLoS Negl Trop Dis (2012) 1.32
West Nile Virus isolation in human and mosquitoes, Mexico. Emerg Infect Dis (2005) 1.32
Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol (2007) 1.30
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine (2005) 1.30
Year-round West Nile virus activity, Gulf Coast region, Texas and Louisiana. Emerg Infect Dis (2004) 1.28
Experimental infection of prairie dogs with monkeypox virus. Emerg Infect Dis (2005) 1.28
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Vaccine (2011) 1.26
Biting rates and developmental substrates for biting midges (Diptera: Ceratopogonidae) in Iquitos, Peru. J Med Entomol (2003) 1.26
Characterization of a novel Negevirus and a novel Bunyavirus isolated from Culex (Culex) declarator mosquitoes in Trinidad. J Gen Virol (2013) 1.26
Biological and phylogenetic characterization of pigeon paramyxovirus serotype 1 circulating in wild North American pigeons and doves. J Clin Microbiol (2008) 1.25
Acute spotted fever rickettsiosis among febrile patients, Cameroon. Emerg Infect Dis (2004) 1.25
Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis (2004) 1.25
Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J Virol (2005) 1.22
NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22
Evolution of new genotype of West Nile virus in North America. Emerg Infect Dis (2011) 1.20
Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A (2012) 1.20
A proposal to change existing virus species names to non-Latinized binomials. Arch Virol (2010) 1.18
Liao ning virus, a new Chinese seadornavirus that replicates in transformed and embryonic mammalian cells. J Gen Virol (2006) 1.17
Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg (2007) 1.15
Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect Dis (2016) 1.15